Company Listing
Personalis

Personalis provides researchers, clinicians and pharmaceutical companies with highly accurate sequencing and interpretation of human exomes and genomes. The company is based on proprietary technology originally developed at Stanford University. CEO, John West, was formerly CEO of the next-generationsequencing (NGS) company, Solexa (a former Abingworth portfolio company), which was acquired by Illumina in 2007 and became the basis for Illumina’s NGS product line.

BACK
Location
Menlo Park, California
CEO
John West
Abingworth Partner
Vincent Miles
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Personalis provides researchers, clinicians and pharmaceutical companies with highly accurate sequencing and interpretation of human exomes and genomes. The company is based on proprietary technology originally developed at Stanford University. CEO, John West, was formerly CEO of the next-generationsequencing (NGS) company, Solexa (a former Abingworth portfolio company), which was acquired by Illumina in 2007 and became the basis for Illumina’s NGS product line.

Location
Menlo Park, California
CEO
John West
Abingworth Partner
Vincent Miles
Website Address
BACK
 
Copyright Abingworth 2017